Latest Asx News

Auckland International Airport confirms the share allotment price for its Dividend Reinvestment Plan tied to the 2025 half-year dividend, signalling steady shareholder returns.

KMD Brands has requested a voluntary suspension of its shares on both the NZX and ASX as it finalises a capital raise, refinancing, and its half-year financial results. The suspension aims to maintain market order while key details remain under negotiation.

Excelsior Capital Limited has announced a further fully franked special dividend of over $10 million amid its ongoing winding up process, alongside key board changes and plans for final capital returns.

Forrestania Resources has inked a binding agreement with Polaris Engineering to construct a new carbon-in-leach plant at Lake Johnston, aiming for commissioning by November 2026 and a throughput of 3.2 million tonnes per annum.

DGL Group Limited has replaced its ANZ-led financing with a new $120 million facility from ScotPac, extending maturity and enhancing working capital flexibility amid ongoing management restructuring.

Ramelius Resources has updated its dividend announcement for the six months ending December 2025, confirming a fully franked dividend of 3 cents per share and setting the Dividend Reinvestment Plan issue price at AUD 3.5244.

iCandy Interactive has announced plans for Lemon Sky Studios to pursue a US IPO on the NYSE American, targeting a US$15 million capital raise, while highlighting strategic pivots in AI and blockchain markets.

Sequoia Financial Group has postponed its interim dividend payment to mid-May as it finalises the sale of InterPrac and awaits ASX guidance on a potential shareholder meeting.

Fatfish Group has revealed improper conduct by a former service provider that delayed its 2024 financial reporting, while outlining ongoing legal actions and a strategy to relist on the ASX within four months.

Killi Resources Limited has successfully completed the first tranche of its share placement, issuing over 26 million shares to raise just over $1 million. The company confirms full regulatory compliance with no undisclosed information.

Kjerulf David Hastings Ainsworth has initiated a second unconditional off-market takeover bid for 5.5% of Ainsworth Game Technology shares at a significant premium, aiming to increase his stake and influence in the company.

Lumos Diagnostics has secured a pivotal US FDA CLIA waiver for its FebriDx® test, vastly expanding its market reach and triggering milestone payments that bolster its US commercial rollout.